Search results
Lake Street Capital Increases Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $75.00
ETF DAILY NEWS· 14 hours agoTandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective upped by Lake Street Capital from $60.00 to $75.00 in a note issued to investors on Wednesday, ...
Semaglutide significantly reduces risk of complications in patients with type 2 diabetes, study...
Medical Xpress· 1 hour agoA pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 & ...
Ozempic reduces risk of serious illness and death in people withdiabetes and kidney disease, study...
News Channel Nebraska· 7 hours agoBy Deidre McPhillips, CNN
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up After Analyst Upgrade
ETF DAILY NEWS· 16 hours agoTandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) shares gapped up before the market opened on Wednesday after Lake Street Capital raised their price target on the ...
High price of popular diabetes drugs deprives low-income people of effective treatment
PhillyVoice.com· 10 hours agoFor the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes,...
Prescriptions for weight loss, diabetes drugs for young people leaped 600% since 2020, study says
CNN.com· 20 hours agoThe number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic...
Ozempic cuts kidney-disease risks, research finds
Market Watch· 4 hours agoNovo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, ...
Skyrocketing diabetes medication costs force life-and-death decisions for patients
FOX 5 Atlanta· 14 hours agoPrices for critical medication are on the rise. ATLANTA - The cost of diabetes medications is on the...
Novo’s Ozempic Slashes Risk of Death in Kidney Disease Study
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Novo Nordisk A/S’s blockbuster diabetes drug Ozempic cut patients’ risk of dying in a...
Ozempic Cuts Risk of Chronic Kidney Disease Complications, Study Finds
New York Times· 7 hours agoA major clinical trial showed such promising results that the drug’s maker halted it early. Dani...